Home About ATSDR Press Room A-Z Index Glossary Employment Training Contact Us CDC  
ATSDR/DHHS Agency for Toxic Substances and Disease Registry Agency for Toxic Substances and Disease Registry Department of Health and Human Services ATSDR en Español

Search:

Report Contents
 
Charge to the Panel
Panel Members
 
Fate & Biomonitoring
 
Sampling Methodologies
Health Endpoints
Susceptible Populations
Exposure Evaluation
Biomonitoring
 
Correlation of Data
 
Risk Management
 
Relocation Criteria
 
Reference Doses
 
Decontamination
 
Recommendations
 
Clinical Evaluation
 
Appropriate Triggers
Health Status
Environmental Medicine
 
Evaluation Protocol
 
Standardizing Lab Data
Treatment
Neurobehavioral Effects
Acute Poisoning
Suggested Evaluation
 
Overarching Issues
 
Recommendations
Field Survey
7-day Study
Dermal Absorption
Subchronic Toxicity
Pilot Study
Cohort Study
 
Selected References
 
Risk Communication
 
Workgroup
Recommendations
Operating Procedures
Management & Planning
Limitations of Strategies
Planning Steps
Identifying Populations
Preventing Exposures
Research Needs
Conclusions
 
Risk Documents
 
Cancer Policy
Risk Assessment
Communication Primer
Evaluation Primer
Psychologial Responses
 
ATSDR Resources
 
Case Studies (CSEM)
Exposure Pathways
GATHER (GIS)
HazDat Database
Health Assessments
Health Statements
Interaction Profiles
Interactive Learning
Managing Incidents
Medical Guidelines
Minimal Risk Levels
Priority List
ToxFAQs™
ToxFAQs™ CABS
Toxicological Profiles
Toxicology Curriculum
 
External Resources
 
CDC
eLCOSH
EPA
Healthfinder®
Medline Plus
NCEH
NIEHS
NIOSH
OSHA
 

Agency for Toxic Substances and Disease Registry (ATSDR) 
Methyl Parathion Expert Panel Report
Issue: Decontamination Criteria


The proposed criteria do not address the decontamination of environmental surfaces that may be sources of exposure. The criteria rely on repeated urine analyses as a basis for determining exposure and, by inference, the potential for future exposure above criteria after urine sampling has terminated. In EPA's removal program, decontamination criteria are used that identify an indoor surface level (using a wipe sample) that "triggers" a decontamination procedure regardless of the urine PNP findings. Such criteria would supposedly add a margin of safety against the failure of urine analyses to predict future exposure and to protect more susceptible potential future occupants. Are such criteria needed and, if so, what would be the basis for establishing quantitative criteria? Also, if decontamination criteria were established, what level of MP should be achieved to declare a residence decontaminated?

The work group recognizes the possibility that biomonitoring of urinary PNP may have some false negative results. The Center for Environmental Health Laboratory that is conducting these analyses reports that, in approximately 1 out of every 200 samples, interfering substances in the urine (as yet unidentified) may prevent detection of urinary PNP. To minimize this possibility, we recommend that in certain circumstances (where there is an imminent hazard of exposure leading to poisoning), relocation criteria should be modified to include consideration of environmental sampling results in the absence of elevated urinary PNP results.

  1. In imminent hazard situations, the local public health agency should have the flexibility to advise relocation on the basis of environmental sampling alone, even in the absence of elevated urinary PNP results. An imminent hazard situation is defined as environmental MP contamination that could reasonably result in acute MP poisoning (OP syndrome with cholinesterase inhibition) in a member of the household. A documented case of OP poisoning of household members or pets in an MP-contaminated household should serve as presumptive evidence of an imminent hazard situation.
  2. Local public health agencies should also have the flexibility to increase the frequency of urinary PNP biomonitoring if they suspect the possibility of false negative results.
  3. Rechecking urinary PNP after members of a household reoccupy a remediated residence would add an additional safeguard to the adequacy of remediation. Whether testing needs to be a continuing practice would be determined by examining the data on postremediation urinary PNPs as they become available.

Top of Page


Revised April 24-25, 1997.